Results 21 to 30 of about 243,892 (195)

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis [PDF]

open access: yesClinicoEconomics and Outcomes Research, 2017
Kirk Geale,1,2 Ertan Saridogan,3 Matthieu Lehmann,4 Pablo Arriagada,4 Marcus Hultberg,2 Martin Henriksson5 1Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 2PAREXEL International, Stockholm, Sweden; 3Women ...
Geale K   +5 more
doaj   +2 more sources

Ulipristal Asetatın Ratlarda Oluşturulan Cerrahi Endometriozise Etkisi [PDF]

open access: yes, 2022
Amaç: Ulipristal Asetat'ın ratlarda oluşturulan endometriozis odakları üzerindeki etkisinin araştırılması hedeflendi. Gereç ve Yöntem: Çalışma, yaklaşık 280 gram ağırlığında 12 haftalık ratlarla yürütüldü.
Bülent DEMİR   +7 more
core   +1 more source

A comparative prospective observational study on the use of ulipristal acetate versus mifepristone in reduction of the size of uterine leiomyoma

open access: yesAsian Journal of Medical Sciences, 2022
Background: Fibroid or uterine leiomyoma is the most common benign tumor of the uterus in the reproductive age group and found in one out of every four women.
Lipika Ghosh   +2 more
doaj   +1 more source

Hormonal assessment of patients of reproductive age with uterine myoma for surgical treatment

open access: yesМедицинский совет, 2019
Aim: To assess the efficacy and safety of ulipristal acetate (UA) use in uterine myoma patients before surgical treatment. Material and methods: 78 patients of reproductive age with uterine bleeding and anemia, who underwent laparoscopic myomectomy, were
A. V. Kozachenko   +4 more
doaj   +1 more source

Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis [PDF]

open access: yes, 2016
Objective: Ulipristal acetate has been found to be non-inferior to other pre-operative treatments of uterine fibroids, particularly leuprolide. The objective of this study was to assess the pharmacoeconomic profile of ulipristal acetate compared to ...
PharmacoTherapy, -Epidemiology and -Economics   +8 more
core   +4 more sources

CLINICAL AND MORPHOLOGICAL RATIONALE FOR THE ULIPRISTAL ACETATE PRE-OPERATION TREATMENT BEFORE ORGANPRESERVING OPERATIONS IN MYOMAS UTERUS PATIENTS WITH THE INTRAUTERINE BLEEDING AND ANAEMIA

open access: yesМедицинский совет, 2017
Objective: assessment of the feasibility and safety of the use of ulipristal acetate on the basis of the clinical and morphological study.Materials and methods: the study involved 78 women with leiomyoma, abundant menstruation and anemia.
A. V. Kozachenko   +3 more
doaj   +1 more source

Long-term intermittent pharmacological therapy of uterine fibroids – a possibility to avoid hysterectomy and its negative consequences

open access: yesMenopause Review, 2016
Uterine fibroids are found in almost 20-40% of women of reproductive age. For each woman an individualised treatment method should be applied because the hysterectomy procedure is not a good option in every case. The uterus is an organ necessary not only
Anita Olejek   +2 more
doaj   +1 more source

Progesterone “against” progesterone. New links in the pathogenesis and future strategies in treatment of uterine fibroids

open access: yesРепродуктивная эндокринология, 2018
Uterine myoma is a benign monoclonal solid tumor of the pelvis emanating from the smooth muscle tissue of the myometrium. Previously, it was considered that only hyperestrogens are the cause of the appearance and growth of fibromatosis.
А. Н. Григоренко
doaj   +1 more source

Effect of a Selective Progesterone Receptor Modulator on Induction of Apoptosis in Uterine Fibroids In Vivo

open access: yesInternational Journal of Endocrinology, 2012
Aim. To determine if hormonal treatment induces apoptosis in uterine fibroids. Methods. Immunohistochemical examination of fibroid tissue, using avidin-biotin complex and cleaved caspase-3 antibody for detecting apoptosis, was performed in premenopausal ...
Petr Horak   +6 more
doaj   +1 more source

Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis.

open access: yesPLoS ONE, 2017
BackgroundMyomectomy has potential risks of complications. To reduce these risks, medical pre-treatment can be applied to reduce fibroid size and thereby potentially decrease intra-operative blood loss, the need for blood transfusion and emergency ...
Inge de Milliano   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy